A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

The latest trading session saw CVS Health (CVS) ending at $45.78, denoting a -0.09% adjustment from its last day's close. This change was narrower than the S&P 500's 1.11% loss on the day. Meanwhile, ...

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price ...

CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

Just more than five years ago, the Minnesota Legislature attempted to rein in the oft-critiqued PBM industry by passing a law that allowed the state to regulate the companies to protect consumers and ...

Pharmacy benefit managers negotiate drug costs with pharmacies ... 502.07 in afternoon trading. "CVS leverages free-market competition to fight back against pharma price gouging, and we are ...